Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis |
Aortic Stenosis | Phase2 | Austria Belgium Canada Czechia Denmark France Germany Israel Italy Netherlands Portugal Spain Switzerland United Kingdom United States View all |
NCT05646381 |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase3 | Argentina Brazil Bulgaria Canada China Croatia Czechia Estonia France Germany Greece India Italy Japan Mexico Poland Portugal Puerto Rico Romania Slovakia Slovenia South Africa Spain Sweden Turkey (Türkiye) United Kingdom United States View all |
NCT05156281 |
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan |
Prostate Cancer | Phase2 | Japan | NCT05114746 |
Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma |
Newly Diagnosed and Recurrent Glioblastoma | Phase1 | France Germany Israel Italy Portugal Spain United Kingdom United States View all |
NCT05739942 |
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer |
Metastatic Castration Resistant Prostate Cancer | Germany | NCT06517719 | |
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase3 | Brazil Canada China France Germany Greece India Israel Italy Japan Netherlands Spain Switzerland Turkey (Türkiye) United Kingdom United States View all |
NCT04817618 |
A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis |
Multiple Sclerosis | Germany | NCT06551519 | |
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) |
Systemic Lupus Erythematosus | Phase3 | Argentina Brazil Bulgaria Canada China Colombia Czechia Guatemala Hungary Israel Japan Poland Portugal Singapore Slovakia South Africa Spain Thailand Turkey (Türkiye) United States View all |
NCT05639114 |
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® |
Asthma | South Korea | NCT05217810 | |
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. |
Oligometastatic Prostate Cancer (OMPC) | Phase3 | Argentina Australia Belgium Brazil Canada China Czechia France Germany Greece Hungary Israel Italy Japan Malaysia Mexico Netherlands Puerto Rico Singapore Slovakia Spain Switzerland Taiwan United Kingdom United States View all |
NCT05939414 |